Research programme: cancer vaccines - MaxygenAlternative Names: Cancer vaccines research programme - Maxygen; Maxy 1200
Latest Information Update: 07 Jun 2013
At a glance
- Originator Maxygen
- Class Cancer vaccines; DNA vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cancer; Colorectal cancer
Most Recent Events
- 07 Jun 2013 Discontinued - Preclinical for Colorectal cancer in USA (unspecified route)
- 07 Jun 2013 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 06 Jun 2006 No development reported - Preclinical for Cancer in USA (unspecified route)